CONRIG PHARMA ApS

CVR 33373236 · Private limited company (ApS) · Active · Medium risk

CONRIG PHARMA ApS is a Private limited company (ApS), founded on , based in Vedbæk. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 15 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 0 and a net result of DKK -96k. CEO: Lars Christer Fredrik Fåhraeus, Snickar Karl Johan Tobieson.

Bankruptcy risk for CONRIG PHARMA ApS

1.4%
probability of bankruptcy within 12 months
Medium risk

1.0 × the average (1.41%) · higher risk than 77% of active Danish companies

Lowest riskHighest risk

Increases the risk

Return on assets< -20% · bankruptcy rate 16.7%1.9×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Equity vs. share capital0–0.5× · bankruptcy rate 11.1%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Equity ratio0%–10% · bankruptcy rate 10.2%1.2×

Reduces the risk

Published annual reports10+ · bankruptcy rate 3.0%0.35×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Number of auditors (historical)2 · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
33373236
Status
Active
Company type
Private limited company (ApS)
Founded
(15 years)
Address
Fagerparken 33
2950 Vedbæk
Municipality
Hørsholm
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 124k
Employees
0 (2011)
Auditor
PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 15
Missing annual reportNo
Negative equityNo
Equity ratio0.0%
Current ratio100%
Moves (last 2 years)0
CEO changes in total4
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -99kDKK -92k
Net profitDKK -96kDKK -100k
EquityDKK 0DKK 25k
Total assetsDKK 66kDKK 69k
CashDKK 21k–
Short-term debtDKK 66k–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Eriksen Funch, Statsautoriseret Revisions­aktie­selskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025105
1 Jan 2024 – 31 Dec 202464
1 Jan 2023 – 31 Dec 202373
1 Jan 2022 – 31 Dec 2022142
1 Jan 2021 – 31 Dec 2021109
1 Jan 2020 – 31 Dec 202060
1 Jan 2019 – 31 Dec 2019111
1 Jan 2018 – 31 Dec 201877
1 Jan 2017 – 31 Dec 2017155
1 Jan 2016 – 31 Dec 2016149
1 Jan 2015 – 31 Dec 2015155
1 Jan 2014 – 31 Dec 2014153
1 Jan 2013 – 31 Dec 2013147
1 Jan 2012 – 31 Dec 2012154
20 Dec 2010 – 31 Dec 2011159

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOLars Christer Fredrik FåhraeusCurrent
CEOSnickar Karl Johan TobiesonCurrent
CEOJohn Bondo Hansen
CEOMikael Søndergaard Thomsen
BoardNiels SkjærbækCurrent
BoardLars Christer Fredrik FåhraeusCurrent
BoardSnickar Karl Johan TobiesonCurrent
BoardJohn Bondo Hansen
BoardFrank Knudsen
BoardElse Sissel Vorstrup
BoardJohn Bondo Hansen
BoardMikael Søndergaard Thomsen
Owner (100%)Melius Pharma ABCurrent
Owner (100%)CONCIT PHARMA HOLDING ApS
Owner (67%)CONCIT PHARMA HOLDING ApS
Owner (25%)FAB5 Holding ApS
Owner (33%)JBHA Holding ApS
Owner (33%)Thomsen Pharma ApS
AuditorPKF Munkebo Eriksen Funch, Statsautoriseret RevisionsaktieselskabCurrent
AuditorEY Godkendt Revisionspartnerselskab
FounderCONCIT PHARMA HOLDING ApSCurrent

The CEOs' other companies

John Bondo Hansen – 7 other companies

Mikael Søndergaard Thomsen – 7 other companies

Address history (2 moves)

Fagerparken 33, 2950 Vedbæk
Ole Maaløes Vej 3, 2200 København N
Langåsen 3, 4450 Jyderup

Employees per year

Number of employees at CONRIG PHARMA ApS per year112011: 02011

Other companies at the same address

Similar companies in Hørsholm

Questions and answers about CONRIG PHARMA ApS

Has CONRIG PHARMA ApS gone bankrupt?

No, CONRIG PHARMA ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of CONRIG PHARMA ApS?

Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.

Who is the CEO of CONRIG PHARMA ApS?

Lars Christer Fredrik Fåhraeus, Snickar Karl Johan Tobieson are the CEOs of CONRIG PHARMA ApS.

Who is the auditor of CONRIG PHARMA ApS?

CONRIG PHARMA ApS most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.

When was CONRIG PHARMA ApS founded?

CONRIG PHARMA ApS was founded on 20 December 2010.

What is the equity of CONRIG PHARMA ApS?

Equity was DKK 0 according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.